Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC5083 | Cinacalcet (AMG-073) HCl Featured |
AMG-073 HCl (Cinacalcet HCl) represents a new class of compounds for the treatment of hyperparathyroidism.
More description
|
![]() |
DC8801 | Cinacalcet (AMG-073) Featured |
Cinacalcet(AMG-073) is an orally active, second-generation calcimimetic compound; AMG 073 represents a new class of compounds for the treatment of hyperparathyroidism.
More description
|
![]() |
DC7020 | Ibutamoren mesylate Featured |
Ibutamoren mesylate (MK-0677) is an orally active nonpeptide growth hormone (GH) secretagogue.
More description
|
![]() |
DC10531 | PCO371 Featured |
PCO371 is a novel, orally active small molecule that acts as a full agonist of PTHR1.
More description
|
![]() |
DC8177 | Enclomiphene citrate Featured |
Enclomiphene is a non-steroidal estrogen receptor antagonist that promotes gonadotropin-dependent testosterone secretion by the testes.
More description
|
![]() |
DC7480 | PF-3274167(cligosiban) Featured |
PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM.
More description
|
![]() |
DC22584 | Mavorixafor(AMD-070) Featured |
A potent and selective antagonist of CXCR4 with IC50 of 13 nM in a CXCR4 125I-SDF inhibition binding assay.
More description
|
![]() |
DC7357 | Anamorelin Featured |
Anamorelin(RC1291; ONO-7643) is a synthetic orally active ghrelin receptor agonist which is under development for the management of non-small lung cancer associated cachexia/anorexia.
More description
|
![]() |
DC8799 | Avanafil(TA-1790) Featured |
Avanafil(TA-1790) is a potent and highly selective phosphodiesterase-5(PDE-5) inhibitor(IC50=5.2 nM) for erectile dysfunction; lower selectivity against PDE1, PDE6, and PDE11.
More description
|
![]() |
DC5901 | Tadalafil Featured |
Tadalafil is a potent and selective inhibitor of Phosphodiesterase-5 (PDE5) This compound prevents the breakdown of phosphodiesterases, many of which are used as secondary messengers. By preventing the breakdown of these messenger molecules, tadalafil can
More description
|
![]() |
DCAPI1241 | Doxercalciferol (Hectorol) Featured |
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
More description
|
![]() |
DC4133 | Udenafil |
Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED)
More description
|
![]() |
DC11665 | PF-00446687 |
PF-00446687(PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.
More description
|
![]() |
DC11664 | PF-00446687 hydrochloride |
PF-00446687 hydrochloride (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.
More description
|
![]() |
DC6577 | Paricalcitol |
Paricalcitol
More description
|
![]() |
DC11095 | ATR-101 free base |
ATR-101 (PD-132301, Nevanimibe) is a selective and potent inhibitor of ACAT1 with IC50 of 52 nM.
More description
|
![]() |
DC11667 | PF-592379 |
A potent, selective, orally active agonist of dopamine D3 receptor with EC50 of 21 nM.
More description
|
![]() |